Cisplatin-induced, coordinated transcriptional reprogramming of neurotrypsin and other proteases in cisplatin-resistant ovarian cancer cells

被引:0
|
作者
Garcia-Bassets, Ivan [1 ]
Almenar-Queralt, Angels [1 ]
机构
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
来源
FASEB JOURNAL | 2012年 / 26卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Diclofenac potentiates the antitumor effect of cisplatin in a xenograft mouse model transplanted with cisplatin-resistant cells without enhancing cisplatin-induced nephrotoxicity
    Okamoto, Keisuke
    Ueda, Hinata
    Saito, Yoshitaka
    Narumi, Katsuya
    Furugen, Ayako
    Kobayashi, Masaki
    DRUG METABOLISM AND PHARMACOKINETICS, 2021, 41
  • [22] Metformin Sensitizes Cisplatin-induced Apoptosis Through Regulating Nucleotide Excision Repair Pathway In Cisplatin-resistant Human Lung Cancer Cells
    Li, Haiwen
    Yang, Donghong
    Xu, Zumin
    Yang, Liu
    Lin, Jiong
    Cai, Jingyi
    Yang, Li
    LETTERS IN DRUG DESIGN & DISCOVERY, 2022, 19 (12) : 1086 - 1095
  • [23] Genetic varians of DNA repair genes in cisplatin-resistant ovarian cancer cells
    Sagdeeva, Aisylu
    Filina, Julia
    Shamsutdinova, Yana
    Galimova, Rezeda
    Sabirov, Alexey
    Rakhmatullina, Aigul
    Zolotykh, Maria
    Mingaleeva, Rimma
    Rizvanov, Albert
    Miftakhova, Regina
    CELL DEATH DISCOVERY, 2022, 8 : 10 - 11
  • [24] ALTERED CISPLATIN METABOLISM IN CISPLATIN-RESISTANT 2008 HUMAN OVARIAN-CARCINOMA CELLS
    ANDREWS, PA
    KIM, RW
    MURPHY, MP
    HOWELL, SB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 270 - 270
  • [25] GALLIC ACID EXHIBITS LOWER CYTOTOXICITY ON NORMAL OVARIAN CELLS THAN CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT OVARIAN CANCER CELLS
    Al Balushi, N.
    Abdulla, N.
    Al Dhahli, B.
    Hasan, I.
    Dobretsov, S.
    Al Bahlani, S.
    Tsang, B.
    Tamimi, Y.
    Burney, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A430 - A430
  • [26] Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells
    Jiang, Li
    Luo, Ruo-Yu
    Yang, Jing
    Cheng, Yan-Xiang
    MOLECULAR MEDICINE REPORTS, 2013, 7 (02) : 425 - 430
  • [27] Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells
    Zhang, Ruitao
    Shi, Huirong
    Ren, Fang
    Li, Xia
    Zhang, Minghui
    Feng, Wei
    Jia, Yanyan
    ONCOLOGY REPORTS, 2016, 35 (04) : 2466 - 2472
  • [28] RESTORATIVE EFFECTS OF CALMODULIN ANTAGONISTS ON REDUCED CISPLATIN UPTAKE BY CISPLATIN-RESISTANT HUMAN OVARIAN-CANCER CELLS
    KIKUCHI, Y
    IWANO, I
    MIYAUCHI, M
    SASA, H
    NAGATA, I
    KUKI, E
    GYNECOLOGIC ONCOLOGY, 1990, 39 (02) : 199 - 203
  • [29] Low-dose LBH589 increases the sensitivity of cisplatin to cisplatin-resistant ovarian cancer cells
    Ma, Yen-Ying
    Lin, Hao
    Moh, Jau-Sung
    Chen, Kuang-Den
    Wang, I-Wen
    Ou, Yu-Che
    You, Ying-Shu
    Lung, Chia-Chi
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2011, 50 (02): : 165 - 171
  • [30] Poly(amido)amine (PAMAM) dendrimer-cisplatin complexes for chemotherapy of cisplatin-resistant ovarian cancer cells
    Yellepeddi, Venkata Kashyap
    Vangara, Kiran Kumar
    Palakurthi, Srinath
    JOURNAL OF NANOPARTICLE RESEARCH, 2013, 15 (09)